AAAAAA
Results:
1-14
|
Results: 14
Authors:
Ikonen, T
Matikainen, M
Mononen, N
Hyytinen, ER
Helin, HJ
Tommola, S
Tammela, TLJ
Pukkala, E
Schleutker, J
Kallioniemi, OP
Koivisto, PA
Citation: T. Ikonen et al., Association of E-cadherin germ-line alterations with prostate cancer, CLIN CANC R, 7(11), 2001, pp. 3465-3471
Authors:
Rokman, A
Koivisto, PA
Matikainen, MP
Kuukasjarvi, T
Poutiainen, M
Helin, HJ
Karhu, R
Kallioniemi, OP
Schleutker, J
Citation: A. Rokman et al., Genetic changes in familial prostate cancer by comparative genomic hybridization, PROSTATE, 46(3), 2001, pp. 233-239
Authors:
Haapala, K
Rokman, A
Palmberg, C
Hyytinen, ER
Laurila, M
Tammela, TLJ
Koivisto, PA
Citation: K. Haapala et al., Chromosomal changes in locally recurrent, hormone-refractory prostate carcinomas by karyotyping and comparative genomic hybridization, CANC GENET, 131(1), 2001, pp. 74-78
Authors:
Koivisto, PA
Mustonen, A
Citation: Pa. Koivisto et A. Mustonen, Primary spontaneous pneumothorax in two siblings suggests autosomal recessive inheritance, CHEST, 119(5), 2001, pp. 1610-1612
Authors:
Rokman, A
Ikonen, T
Mononen, N
Autio, V
Matikainen, MP
Koivisto, PA
Tammela, TLJ
Kallioniemi, OP
Schleutker, J
Citation: A. Rokman et al., ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer, CANCER RES, 61(16), 2001, pp. 6038-6041
Authors:
Mononen, N
Ikonen, T
Syrjakoski, K
Matikainen, M
Schleutker, J
Tammela, TLJ
Koivisto, PA
Kallioniemi, OP
Citation: N. Mononen et al., A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland, BR J CANC, 84(10), 2001, pp. 1344-1347
Authors:
Hernes, EH
Linja, M
Fossa, SD
Visakorpi, T
Berner, A
Winderen, M
Koivisto, PA
Citation: Eh. Hernes et al., Hormone-resistant prostate cancer with symptomatic pelvic tumours: patientsurvival and prognostic factors, BJU INT, 86(3), 2000, pp. 240-247
Authors:
Haapala, K
Lehtimaki, T
Ilveskoski, E
Koivisto, PA
Citation: K. Haapala et al., Apolipoprotein E genotype is not linked to locally recurrent hormone-refractory prostate cancer, PROSTATE C, 3(2), 2000, pp. 107-109
Authors:
Palmberg, C
Rantala, I
Tammela, TLJ
Helin, H
Koivisto, PA
Citation: C. Palmberg et al., Low apoptotic activity in primary prostate carcinomas without response to hormonal therapy, ONCOL REP, 7(5), 2000, pp. 1141-1144
Authors:
Mononen, N
Syrjakoski, K
Matikainen, M
Tammela, TLJ
Schleutker, J
Kallioniemi, OP
Trapman, J
Koivisto, PA
Citation: N. Mononen et al., Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene, CANCER RES, 60(22), 2000, pp. 6479-6481
Authors:
Koivisto, PA
Schleutker, J
Helin, H
Ehren-van Eekelen, C
Kallioniemi, OP
Trapman, J
Citation: Pa. Koivisto et al., Androgen receptor gene alterations and chromosomal gains and losses in prostate carcinomas appearing during finasteride treatment for benign prostatic hyperplasia, CLIN CANC R, 5(11), 1999, pp. 3578-3582
Authors:
Koivisto, PA
Koivisto, H
Haapala, K
Simola, KOJ
Citation: Pa. Koivisto et al., A de novo deletion of chromosome 15(q15.2q21.2) in a dysmorphic, mentally retarded child with congenital scalp defect, CLIN DYSMOR, 8(2), 1999, pp. 139-141
Authors:
Koivisto, PA
Helin, HJ
Citation: Pa. Koivisto et Hj. Helin, Androgen receptor gene amplification increases tissue PSA protein expression in hormone-refractory prostate carcinoma, J PATHOLOGY, 189(2), 1999, pp. 219-223
Authors:
Koivisto, PA
Rantala, I
Citation: Pa. Koivisto et I. Rantala, Amplification of the androgen receptor gene is associated with p53 mutation in hormone-refractory recurrent prostate cancer, J PATHOLOGY, 187(2), 1999, pp. 237-241
Risultati:
1-14
|